Archiv der Pharmazie
短名 | Arch Pharm |
Journal Impact | 4.49 |
国际分区 | PHARMACOLOGY & PHARMACY(Q1) |
期刊索引 | SCI Q1中科院 3 区 |
ISSN | 0365-6233, 1521-4184 |
h-index | 73 |
国内分区 | 医学(3区)医学化学综合(2区)医学药学(2区)医学药物化学(3区) |
ARCHIV DER PHARMAZIE - CHEMISTRY IN LIFE SCIENCES 是一份致力于药物和药物化学各个领域研究和开发的国际期刊。重点放在将合成有机化学、结构生物学、分子建模、生物有机化学、天然产物化学、生物化学或分析方法与生物活性等药物或医学方面相结合的论文。该期刊的重点是原创研究论文,但也欢迎其他具有科学价值的贡献(例如评论、小型评论、亮点、专题讨论会贡献、讨论和论文)。
期刊主页投稿网址涉及主题 | 化学立体化学 |
出版信息 | 出版商: Wiley-VCH Verlag,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1950,原创研究文献占比: 80.49%,自引率:4.70%, Gold OA占比: 17.00% |
平均审稿周期 | 网友分享经验:平均3.0个月 |
平均录用比例 | 网友分享经验:较易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
New hydrazide derivatives of <i>N</i>‐amino‐11‐azaartemisinin as promising epidermal growth factor receptor inhibitors for therapeutic development in triple‐negative breast cancer
2024-9-13
In vitro assessment of skin permeation properties of enzymatically derived oil‐based fatty acid esters of vitamin C
2024-9-13
Repurposing antiparasitic <i>N,N′</i>‐aliphatic diamine derivatives as promising antimycobacterial agents
2024-9-12
Amorphous silica nanoparticles exhibit antitumor activity in triple‐negative breast cancer cells
2024-9-10
Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies
2024-9-6
<i>Hibiscus schizopetalus</i> boosts wound healing via restoring redox balance and hindering inflammatory responses in rats: Insights on metabolome profiling and molecular docking
2024-9-6
From dyes to drugs: The historical impact and future potential of dyes in drug discovery
2024-9-6
Exploring the chemical space around chrysin to develop novel vascular Ca<sub>V</sub>1.2 channel blockers, promising vasorelaxant agents
2024-9-6
Insights into medicinal attributes of imidazo[1,2‐<i>a</i>]pyridine derivatives as anticancer agents
2024-9-2
Issue Information: Arch Pharm (9/2024)
2024-9-1
Cyclization of acyl thiosemicarbazides led to new <i>Helicobacter pylori</i> α‐carbonic anhydrase inhibitors
2024-8-29
DNA interaction of selected tetrahydropyrimidine and its effects against CCl<sub>4</sub>‐induced hepatotoxicity in vivo: Part II
2024-8-27
Green preparation and evaluation of the anti‐psoriatic activity of vesicular elastic nanocarriers of kojic acid from <i>Aspergillus oryzae</i> N12: Repurposing of a dermo‐cosmetic lead
2024-8-23
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions
2024-8-23
Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease
2024-8-15
An in‐depth analysis of COVID‐19 treatment: Present situation and prospects
2024-8-6
Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells
2024-8-6
Synthesis, in vitro anticancer activity, and pharmacokinetic profiling of the new tetrahydropyrimidines: Part I
2024-8-5
Facile one‐pot synthesis of <i>N‐</i>pyridinylaminonaphthol derivatives and their antibacterial evaluation against multidrug‐resistant <i>Staphylococcus aureus</i>
2024-8-5
Issue Information: Arch Pharm (8/2024)
2024-8-1
Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR‐2 and EGFR<sup>T790M</sup>: Molecular docking, ADMET, design, and syntheses
2024-8-1
Unlocking the potential of edible <i>Ulva</i> sp. seaweeds: Metabolomic profiling, neuroprotective mechanisms, and implications for Parkinson's disease management
2024-7-31
Mono‐ and bis(steroids) containing a cyclooctane core: Synthesis, antiproliferative activity, and action on cell cytoskeleton microtubules
2024-7-30
Tail‐approach based design, synthesis, and molecular modeling of benzenesulfonamides carrying thiadiazole and urea moieties as novel carbonic anhydrase inhibitors
2024-7-30
Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade
2024-7-29
Novel drug design and repurposing: An opportunity to improve translational research in cardiovascular diseases?
2024-7-29
Synthesis of new phenothiazine derivatives: Molecular docking, assessment of cytotoxic activity and oxidant–antioxidant properties on PCS‐201‐012, HT‐29, and SH‐SY5Y cell lines
2024-7-26
Natural flavonoids as promising lactate dehydrogenase A inhibitors: Comprehensive in vitro and in silico analysis
2024-7-25
CAPE derivatives: Multifaceted agents for chronic wound healing
2024-7-25
New potent muscarinic receptor ligands bearing the 1,4‐dioxane nucleus: Investigation on the nature of the substituent in position 2
2024-7-25
Correction to: Ecofriendly synthesis of pyrano[2,3‐<i>d</i>]pyrimidine derivatives and related heterocycles with anti‐inflammatory activities
2024-7-24
Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review
2024-7-23
Benzimidazole‐oxindole hybrids: A novel class of selective dual CDK2 and GSK‐3β inhibitors of potent anticancer activity
2024-7-23
<i>Peperomia pellucida</i> (L.) <scp>Kunth</scp> suppresses glycation‐induced inflammatory response in human retinal pigment epithelial cell line ARPE‐19 via JAK‐STAT3 signaling
2024-7-22
Novel 1,2,4‐triazole derivatives containing the naphthalene moiety as selective butyrylcholinesterase inhibitors: Design, synthesis, and biological evaluation
2024-7-21
Structural characterization and bioactivity profiling of the fungal peptaibiotic tolypin reveal protective effects against influenza viruses
2024-7-19
New labdane diterpenoids from <i>Alpinia galanga</i>: A new type of GLP‐1 secretagogues targeting the PKA‐CREB and PI3K‐Akt signaling axes
2024-7-19
A critical review of therapeutic interventions in sickle cell disease: Progress and challenges
2024-7-19
Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐<i>b</i>]pyridazine hybrid derivatives as VEGFR selective inhibitors
2024-7-15
Caffeic acid and its derivative caffeic acid phenethyl ester as potential therapeutic compounds for cardiovascular diseases: A systematic review
2024-7-15
Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
2024-7-14
Utilization of an optimized AlphaFold protein model for structure‐based design of a selective HDAC11 inhibitor with anti‐neuroblastoma activity
2024-7-12
Quinazoline‐oxindole hybrids as angiokinase inhibitors and anticancer agents: Design, synthesis, biological evaluation, and molecular docking studies
2024-7-12
Novel thiazolotriazole and triazolothiadiazine scaffolds as selective tumor associated carbonic anhydrase inhibitors endowed with cathepsin B inhibition
2024-7-11
Current scenario of indole hybrids with antibacterial potential against <i>Acinetobacter baumannii</i> pathogens: A mini‐review
2024-7-10
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents
2024-7-9
The current landscape of coumarin hybrids with antibreast cancer therapeutic applications: An updated review
2024-7-9
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents
2024-7-5
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远